Indaptus Therapeutics INDP
NASDAQ INDP
$2.37 -0.48 (-17.08%)
As of: Sep 30, 2026 · 12:05 PM EDT

Indaptus Therapeutics (INDP) Capital Expenditures (2020 - 2021)

Updated

Indaptus Therapeutics (INDP) recorded Capital Expenditures of $3,854 in FY2021.

Analysis

Indaptus Therapeutics (INDP) Capital Expenditures (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.32 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 322.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -763.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 112.20 Mn
10 Indaptus Therapeutics 210.93 Mn 183.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 1,654.00
Jun 30, 2021 1,200.00
Mar 31, 2021 1,000.00
Mar 31, 2020 3,000.00
API Access

Indaptus Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INDP&period=max&api_key=YOUR_API_KEY